+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Orexo AB - logo

Orexo AB is a specialty pharmaceutical company in the United States. Its launched products include Zubsolv sublingual tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, an active substance zolpidem that is used for the treatment of short-term insomnia. It has collaboration agreement with Mundipharma for the development and commercialization of Zubsolv and with AstraZeneca with regards to the OX-Cysteinyl Leukotriene Inhibitor project. Founded in 1995, the company is headquartered in Uppsala, Sweden.

Naltrexone and Buprenorphine - Global Strategic Business Report - Product Thumbnail Image

Naltrexone and Buprenorphine - Global Strategic Business Report

  • Report
  • June 2025
  • 364 Pages
  • Global
From
Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Opioid Use Disorder Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Opioid Use Disorder Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • July 2023
  • 135 Pages
  • Global
From
Opioid Related Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Related Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • June 2023
  • 204 Pages
  • Global
From
North America Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 84 Pages
  • North America
From
LAMEA Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 94 Pages
  • Middle East, Africa
From
Asia Pacific Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 92 Pages
  • Asia Pacific
From
Europe Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 92 Pages
  • Europe
From
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 560 Pages
  • Global
From
Cancer Pain Management - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management - Global Strategic Business Report

  • Report
  • June 2025
  • 588 Pages
  • Global
From
Opioid Drugs: Global Markets to 2023 - Product Thumbnail Image

Opioid Drugs: Global Markets to 2023

  • Report
  • November 2018
  • 147 Pages
  • Global
From
Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030 - Product Thumbnail Image

Global Cancer Pain Market, By Drug Type, By Disease Indication, Estimation & Forecast, 2017 - 2030

  • Report
  • January 2022
  • 278 Pages
  • Global
From
Addiction Treatment - Global Strategic Business Report - Product Thumbnail Image

Addiction Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 242 Pages
  • Global
From
Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030 - Product Thumbnail Image

Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030

  • Report
  • January 2022
  • 148 Pages
  • Global
From
Addictions Therapeutics Market 2024-2028 - Product Thumbnail Image

Addictions Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 173 Pages
  • Global
From
Cancer Pain Management Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis - Product Thumbnail Image

Cancer Pain Management Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • Report
  • April 2023
  • 450 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Thumbnail Image

Addictions Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
Loading Indicator